The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction

被引:18
|
作者
Ohbayashi, Norihiko [1 ]
Kawakami, Shiho [1 ]
Muromoto, Ryuta [1 ]
Togi, Sumihito [1 ]
Ikeda, Osamu [1 ]
Kamitani, Shinya [1 ]
Sekine, Yuichi [1 ]
Honjoh, Tsutomu [2 ]
Matsuda, Tadashi [1 ]
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Sapporo, Hokkaido 0600812, Japan
[2] Morinaga Inst Biol Sci Inc, Yokohama, Kanagawa 2360003, Japan
关键词
IL-6; LIF; SENP1; SUMO; STAT3; PML; transcriptional regulation;
D O I
10.1016/j.bbrc.2008.04.179
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Post-translational modification by small ubiquitin-like modifier (SUMO) plays an important role in the regulation of different signaling pathways and is involved in the formation of promyelocytic leukemia (PML) Protein nuclear bodies following sumoylation of PML. In the present study, we found that IL-6 induces desumoylation of PML and dissociation between PML and SUMO1 in hepatoma cells. We also found that IL-6 induces mRNA expression of SENP1, a member of the SUMO-specific protease family. Furthermore, wild-type SENP1 but not an inactive SENP1 mutant restored the PML-mediated suppression of STAT3 activation. These results indicate that the IL-6 family of cytokines modulates STAT3 activation by desumoylation and inactivation PML through SENP1 induction. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:823 / 828
页数:6
相关论文
共 50 条
  • [21] A muscle-specific protein ‘myoferlin’ modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus
    A Yadav
    B Kumar
    J C Lang
    T N Teknos
    P Kumar
    Oncogene, 2017, 36 : 6374 - 6382
  • [22] Over Activation of IL-6/STAT3 Signaling Pathway in Juvenile Dermatomyositis
    Zheng, Qi
    Wang, Zhaoling
    Tan, Yejun
    Zhu, Kun
    Lu, Meiping
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1255 - 1269
  • [23] Activation of STAT3 by IL-6 confers drug resistance in Medulloblastoma.
    Sreenivasan, L.
    Wang, H.
    Yap, S.
    Liu, C.
    Leclair, P.
    Liu, C.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
  • [24] Synthesis of Thienopyrimidine Derivatives as Inhibitors of STAT3 Activation Induced by IL-6
    Jang, Hyun-Jae
    Kim, Sung Min
    Rho, Mun-Chual
    Lee, Seung Woong
    Song, Yang-Heon
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 29 (06) : 856 - 862
  • [25] Analysis of the Influence of IL-6 and the Activation of the Jak/Stat3 Pathway in Fibromyalgia
    Marino, Ylenia
    Arangia, Alessia
    Cordaro, Marika
    Siracusa, Rosalba
    D'Amico, Ramona
    Impellizzeri, Daniela
    Cupi, Rosalia
    Peritore, Alessio Filippo
    Gugliandolo, Enrico
    Fusco, Roberta
    Cuzzocrea, Salvatore
    Di Paola, Rosanna
    BIOMEDICINES, 2023, 11 (03)
  • [26] SENP1 regulates TH1 chemokines via IFN-γ-STAT1 signaling in keratinocytes through STAT3-deSUMOylation negative feedback loop
    Lin, F.
    Xu, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (09) : B22 - B22
  • [27] CHONDROPROTECTIVE EFFECTS OF IL-6 INHIBITION THROUGH BLOCKADE OF THE STAT3 PATHWAY
    Latourte, A.
    Cherifi, C.
    Ea, H. -K.
    Bouaziz, W.
    Funck-Brentano, T.
    Solal, M. Cohen
    Hay, E.
    Richette, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 661 - 661
  • [28] Hepatoprotection via the IL-6/Stat3 pathway
    Taub, R
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07): : 978 - 980
  • [29] The role of IL-6 and STAT3 in inflammation and cancer
    Hodge, DR
    Hurt, EM
    Farrar, WL
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (16) : 2502 - 2512
  • [30] Induction of beta cell neogenesis by cytokines of the IL-6 family
    Baeyens, L
    Bouwens, L
    DIABETOLOGIA, 2005, 48 : A151 - A151